Literature DB >> 20430477

Inactivation of influenza A virus H1N1 by disinfection process.

Eun Kyo Jeong1, Jung Eun Bae, In Seop Kim.   

Abstract

BACKGROUND: Because any patient, health care worker, or visitor is capable of transmitting influenza to susceptible persons within hospitals, hospital-acquired influenza has been a clinical concern. Disinfection and cleaning of medical equipment, surgical instruments, and hospital environment are important measures to prevent transmission of influenza virus from hospitals to individuals. This study was conducted to evaluate the efficacy of disinfection processes, which can be easily operated at hospitals, in inactivating influenza A virus H1N1 (H1N1).
METHODS: The effects of 0.1 mol/L NaOH, 70% ethanol, 70% 1-propanol, solvent/detergent (S/D) using 0.3% tri (n-butyl)-phosphate and 1.0% Triton X-100, heat, and ethylene oxide (EO) treatments in inactivating H1N1 were determined. Inactivation of H1N1 was kinetically determined by the treatment of disinfectants to virus solution. Also, a surface test method, which involved drying an amount of virus on a surface and then applying the inactivation methods for 1 minute of contact time, was used to determine the virucidal activity.
RESULTS: H1N1 was completely inactivated to undetectable levels in 1 minute of 70% ethanol, 70% 1-propanol, and solvent/detergent treatments in the surface tests as well as in the suspension tests. H1N1 was completely inactivated in 1 minute of 0.1 mol/L NaOH treatment in the suspension tests and also effectively inactivated in the surface tests with the log reduction factor of 3.7. H1N1 was inactivated to undetectable levels within 5 minutes, 2.5 minutes, and 1 minute of heat treatment at 70, 80, and 90 degrees C, respectively in the suspension tests. Also, H1N1 was completely inactivated by EO treatment in the surface tests.
CONCLUSION: Common disinfectants, heat, and EO tested in this study were effective at inactivating H1N1. These results would be helpful in implementing effective disinfecting measures to prevent hospital-acquired infections. Copyright 2010 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20430477     DOI: 10.1016/j.ajic.2010.03.003

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  16 in total

1.  Production of decellularized porcine lung scaffolds for use in tissue engineering.

Authors:  Jenna L Balestrini; Ashley L Gard; Angela Liu; Katherine L Leiby; Jonas Schwan; Britta Kunkemoeller; Elizabeth A Calle; Amogh Sivarapatna; Tylee Lin; Sashka Dimitrievska; Stuart G Cambpell; Laura E Niklason
Journal:  Integr Biol (Camb)       Date:  2015-10-01       Impact factor: 2.192

2.  A chronicle of SARS-CoV-2: Seasonality, environmental fate, transport, inactivation, and antiviral drug resistance.

Authors:  Manish Kumar; Payal Mazumder; Sanjeeb Mohapatra; Alok Kumar Thakur; Kiran Dhangar; Kaling Taki; Santanu Mukherjee; Arbind Kumar Patel; Prosun Bhattacharya; Pranab Mohapatra; Jörg Rinklebe; Masaaki Kitajima; Faisal I Hai; Anwar Khursheed; Hiroaki Furumai; Christian Sonne; Keisuke Kuroda
Journal:  J Hazard Mater       Date:  2020-10-06       Impact factor: 10.588

3.  Evaluation and clinical validation of an alcohol-based transport medium for preservation and inactivation of respiratory viruses.

Authors:  Kathy Luinstra; Astrid Petrich; Santina Castriciano; Mona Ackerman; Sylvia Chong; Susan Carruthers; Brenna Ammons; James B Mahony; Marek Smieja
Journal:  J Clin Microbiol       Date:  2011-04-20       Impact factor: 5.948

Review 4.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

5.  Incorporation of a proteotyping approach using mass spectrometry for surveillance of influenza virus in cell-cultured strains.

Authors:  Neil D Fernandes; Kevin M Downard
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

6.  Viruses contained in droplets applied on warmed surface are rapidly inactivated.

Authors:  Swan Firquet; Sophie Beaujard; Pierre-Emmanuel Lobert; Famara Sané; Delphine Caloone; Daniel Izard; Didier Hober
Journal:  Microbes Environ       Date:  2014-12-03       Impact factor: 2.912

Review 7.  Sanitizing agents for virus inactivation and disinfection.

Authors:  Qianyu Lin; Jason Y C Lim; Kun Xue; Pek Yin Michelle Yew; Cally Owh; Pei Lin Chee; Xian Jun Loh
Journal:  View (Beijing)       Date:  2020-05-24

8.  Evaluating the virucidal efficacy of hydrogen peroxide vapour.

Authors:  S M Goyal; Y Chander; S Yezli; J A Otter
Journal:  J Hosp Infect       Date:  2014-02-27       Impact factor: 3.926

9.  N 2 gas plasma inactivates influenza virus by inducing changes in viral surface morphology, protein, and genomic RNA.

Authors:  Akikazu Sakudo; Naohiro Shimizu; Yuichiro Imanishi; Kazuyoshi Ikuta
Journal:  Biomed Res Int       Date:  2013-09-30       Impact factor: 3.411

Review 10.  Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination.

Authors:  J A Otter; C Donskey; S Yezli; S Douthwaite; S D Goldenberg; D J Weber
Journal:  J Hosp Infect       Date:  2015-10-03       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.